Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
4.2200
+0.7700
+(22.32%)
At close: February 21 at 4:00:01 PM EST
3.9700
-0.25
(-5.92%)
After hours: February 21 at 7:58:26 PM EST
Breakdown
TTM
Operating Cash Flow
-7,100,008.3230
Investing Cash Flow
28,210.0870
Financing Cash Flow
4,163,034.1730
End Cash Position
696,542.4580
Capital Expenditure
-21,025.9370
Issuance of Debt
5,443,140.5000
Repayment of Debt
-1,262,299.8270
Free Cash Flow
-7,121,034.2600
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FGEN FibroGen, Inc.
0.7059
-8.61%
SLDB Solid Biosciences Inc.
5.78
-3.67%
ADTX Aditxt, Inc.
0.0915
-22.98%
MBRX Moleculin Biotech, Inc.
1.2800
-8.57%
NKGN NKGen Biotech, Inc.
0.5695
+27.12%
APTO Aptose Biosciences Inc.
0.1621
-14.68%
EDIT Editas Medicine, Inc.
1.9200
-6.80%
IVVD Invivyd, Inc.
1.7700
+46.28%
BPTH Bio-Path Holdings, Inc.
0.2100
0.00%
OCEA Ocean Biomedical, Inc.
0.1266
-9.12%